PHILADELPHIA, PA — VintaBio announced it has filed provisional patents with the U.S. Patent and Trademark Office for a new approach to manufacturing biotherapeutics using adherent culturing methods in ...
Proprietary process reduces development timelines from 18 months to as little as 3, eliminates reliance on traditional plastic flatware, and offers rapid, globalization — validated in AAV production.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback